Literature DB >> 25207149

Serum Oestradiol Pattern during Coasting is Different in Antagonist Cycles Compared with Long Agonist Cycles in In Vitro Fertilisation.

Koray Elter1, Tijen Alev Ozay2, Elif Ergin2, Murat Hakan Ozörnek2.   

Abstract

BACKGROUND: GnRH agonists and antagonists have different mechanism of action, and therefore serum estradiol levels might differ during coasting in IVF. AIMS: To compare the change in serum oestradiol levels after withholding the gonadotropins for coasting between long agonist and antagonist cycles. STUDY
DESIGN: Retrospective study.
METHODS: Antagonist and long agonist cycles, in which coasting was performed, were analysed in this retrospective analysis. Antagonist cycles (n=50) were compared with long agonist cycles (n=52) with respect to daily serum oestradiol levels following withholding of gonadotropins.
RESULTS: The pattern of change in serum oestradiol was different between groups; it increased on the first day by 11.2% and decreased thereafter on the second and third days in the agonist group. However, it began to decrease from the first day in the antagonist group. Therefore, peak serum oestradiol levels were significantly higher in the agonist group than in the antagonist group (mean±standard deviation; 5798±1748 vs 5104±1351 pg/mL). The duration of coasting was shorter in the antagonist group compared with that in the agonist group (mean±standard deviation; 2.60±1.40 vs 1.96±0.88 days).
CONCLUSION: Serum oestradiol pattern during coasting is different in antagonist cycles compared with long agonist cycles in in vitro fertilisation.

Entities:  

Keywords:  Estradiol; GnRH antagonists; Ovarian Hyperstimulation Syndrome; coasting

Year:  2013        PMID: 25207149      PMCID: PMC4115938          DOI: 10.5152/balkanmedj.2013.9028

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  20 in total

1.  Treatment with gonadotropin-releasing hormone (GnRH) antagonists in women suppressed with GnRH agonist may avoid cycle cancellation in patients at risk for ovarian hyperstimulation syndrome.

Authors:  Robert L Gustofson; Frederick W Larsen; Mark R Bush; James H Segars
Journal:  Fertil Steril       Date:  2006-01       Impact factor: 7.329

2.  The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles.

Authors:  Ulun Ulug; Mustafa Bahceci; Halit F Erden; Eliezer Shalev; Izhar Ben-Shlomo
Journal:  Hum Reprod       Date:  2002-02       Impact factor: 6.918

3.  Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

Authors:  F Olivennes; J Belaisch-Allart; J C Emperaire; H Dechaud; S Alvarez; L Moreau; B Nicollet; J R Zorn; P Bouchard; R Frydman
Journal:  Fertil Steril       Date:  2000-02       Impact factor: 7.329

4.  Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.

Authors:  C Albano; R E Felberbaum; J Smitz; H Riethmüller-Winzen; J Engel; K Diedrich; P Devroey
Journal:  Hum Reprod       Date:  2000-03       Impact factor: 6.918

5.  Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome.

Authors:  Ragaa Mansour; Mohamed Aboulghar; Gamal Serour; Yehia Amin; Ahmed M Abou-Setta
Journal:  Hum Reprod       Date:  2005-07-08       Impact factor: 6.918

6.  Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins.

Authors:  R N Porter; W Smith; I L Craft; N A Abdulwahid; H S Jacobs
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

7.  High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by 'prolonged coasting' of very hyperstimulated patients: a multicentre study.

Authors:  U Waldenström; J Kahn; L Marsk; S Nilsson
Journal:  Hum Reprod       Date:  1999-02       Impact factor: 6.918

8.  Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome.

Authors:  Robert L Gustofson; James H Segars; Frederick W Larsen
Journal:  Hum Reprod       Date:  2006-09-11       Impact factor: 6.918

9.  Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment.

Authors:  P E Egbase; M Al Sharhan; P Berlingieri; J G Grudzinskas
Journal:  Hum Reprod       Date:  2000-10       Impact factor: 6.918

10.  [Suppression of endogenous LH increase in ovarian stimulation with the GnRH antagonist Cetrorelix].

Authors:  K Diedrich; C Diedrich; E Santos; O Bauer; C Zoll; S al-Hasani; T Reissmann; D Krebs; D Klingmüller
Journal:  Geburtshilfe Frauenheilkd       Date:  1994-04       Impact factor: 2.915

View more
  1 in total

1.  The Effect of Coasting on Intracytoplasmic Sperm Injection Outcome in Antagonist and Agonist Cycle.

Authors:  Z Candan İltemir Duvan; Müberra Namlı Kalem; Yuksel Onaran; Esra Aktepe Keskin; Aylin Ayrım; Aslıhan Pekel; Hasan Kafalı; Nilgün Turhan
Journal:  Int J Fertil Steril       Date:  2016-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.